Billings J - Search Results

1

In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

Kung HF, Alavi A, Chang W, Kung MP, Keyes JW Jr, Velchik MG, Billings J, Pan S, Noto R, Rausch, et al. Kung HF, et al. Among authors: billings j. J Nucl Med. 1990 May;31(5):573-9. J Nucl Med. 1990. PMID: 2140408 Free article.

2

Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.

Murphy RA, Kung HF, Kung MP, Billings J. Murphy RA, et al. Among authors: billings j. J Med Chem. 1990 Jan;33(1):171-8. doi: 10.1021/jm00163a029. J Med Chem. 1990. PMID: 2136916

3

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.

Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A. Kung MP, et al. Among authors: billings j. J Nucl Med. 1990 May;31(5):648-54. J Nucl Med. 1990. PMID: 2140409 Free article.

4

(+/-)-7-chloro-8-hydroxy-1-(4'-[125I]iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine: a potential CNS D-1 dopamine receptor imaging agent.

Chumpradit S, Kung HF, Billings J, Kung MP, Pan S. Chumpradit S, et al. Among authors: billings j. J Med Chem. 1989 Jul;32(7):1431-5. doi: 10.1021/jm00127a005. J Med Chem. 1989. PMID: 2525621

5

Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.

Schonwetter BS, Luedtke RR, Kung MP, Billings J, Kung HF, Molinoff PB. Schonwetter BS, et al. Among authors: billings j. J Pharmacol Exp Ther. 1989 Jul;250(1):110-6. J Pharmacol Exp Ther. 1989. PMID: 2526213

6

[125I](+/-)FISCH: a new CNS D-1 dopamine receptor imaging ligand.

Billings J, Kung MP, Chumpradit S, Pan S, Kung HF. Billings J, et al. Life Sci. 1989;45(8):711-8. doi: 10.1016/0024-3205(89)90090-8. Life Sci. 1989. PMID: 2779358 Free article.

7

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

Kung HF, Pan S, Kung MP, Billings J, Kasliwal R, Reilley J, Alavi A. Kung HF, et al. Among authors: billings j. J Nucl Med. 1989 Jan;30(1):88-92. J Nucl Med. 1989. PMID: 2783457 Free article.

8

Concentration recovery for SPECT CNS dopamine-receptor studies for monkeys.

Shao L, Billings J, Pfeiffer N, Kung HF. Shao L, et al. Among authors: billings j. Med Phys. 1994 May;21(5):675-81. doi: 10.1118/1.597321. Med Phys. 1994. PMID: 7935203

9

Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.

Chumpradit S, Kung MP, Billings J, Mach R, Kung HF. Chumpradit S, et al. Among authors: billings j. J Med Chem. 1993 Jan 22;36(2):221-8. doi: 10.1021/jm00054a005. J Med Chem. 1993. PMID: 8093734

10

Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.

Billings JJ, Kung MP, Chumpradit S, Mozley D, Alavi A, Kung HF. Billings JJ, et al. J Neurochem. 1992 Jan;58(1):227-36. doi: 10.1111/j.1471-4159.1992.tb09300.x. J Neurochem. 1992. PMID: 1530770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters